AI can save lives, but only if we address data security and usability
Pairing AI capabilities with human strengths can bring a competitive edge in this rapidly-changing world.
The effectiveness of AI applications can be undermined by the volumes of unstructured data prevalent in the pharma industry. What can be done to overcome this issue?
South Korea is to build a comprehensive database of genetic and biometric data from 10 million people, in a bid to boost its pharma and biotech industry.
Cutting-edge technologies are increasingly improving pharma’s R&D processes.
Nurse plus digital plus patient equals better outcomes.
Artificial Intelligence (AI), big data and genomics are coming together to revolutionise drug discovery and development.
Graph technology is allowing pharma to model data in a way that offers invaluable insights for marketing, R&D and compliance teams alike.